Miyabi Yamakita
Stock Analyst at Jefferies
(1.40)
# 3,524
Out of 4,491 analysts
86
Total ratings
51.4%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Miyabi Yamakita
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4483 JMDC Inc. | Maintained: Buy | ¥6,400 → ¥5,500 | $3,225.00 | +70.54% | 7 | Jul 6, 2026 | |
| TYO: 4516 Nippon Shinyaku Co., Ltd. | Maintained: Hold | ¥5,200 → ¥4,300 | $4,084.00 | +5.29% | 4 | Jun 30, 2026 | |
| TYO: 4592 SanBio Company Limited | Upgraded: Hold | ¥1,500 → ¥1,200 | $950.00 | +26.32% | 5 | Jun 15, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Hold | ¥1,800 → ¥1,600 | $1,918.00 | -16.58% | 9 | May 28, 2026 | |
| TYO: 4547 Kissei Pharmaceutical Co., Ltd. | Maintained: Buy | ¥5,400 → ¥4,800 | $4,165.00 | +15.25% | 7 | May 25, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Upgraded: Buy | ¥750 → ¥900 | $456.00 | +97.37% | 4 | Apr 16, 2026 | |
| TYO: 2784 Alfresa Holdings Corporation | Maintained: Hold | ¥2,300 → ¥2,400 | $2,230.50 | +7.60% | 4 | Apr 14, 2026 | |
| TYO: 7459 MediPal Holdings Corporation | Maintained: Hold | ¥2,500 → ¥2,700 | $2,752.00 | -1.89% | 9 | Apr 14, 2026 | |
| TYO: 9987 Suzuken Co., Ltd. | Maintained: Buy | ¥6,800 → ¥7,100 | $5,067.00 | +40.12% | 7 | Apr 14, 2026 | |
| TYO: 8129 Toho Holdings Co., Ltd. | Maintained: Hold | ¥5,800 → ¥5,000 | $4,010.00 | +24.69% | 10 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥620 | $103.00 | +501.94% | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥620 → ¥710 | $238.00 | +198.32% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,100 | $1,716.00 | n/a | 13 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,000 | $896.00 | n/a | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥1,900 → ¥2,800 | $1,022.50 | n/a | 2 | Feb 27, 2025 |
JMDC Inc.
Jul 6, 2026
Maintained: Buy
Price Target: ¥6,400 → ¥5,500
Current: $3,225.00
Upside: +70.54%
Nippon Shinyaku Co., Ltd.
Jun 30, 2026
Maintained: Hold
Price Target: ¥5,200 → ¥4,300
Current: $4,084.00
Upside: +5.29%
SanBio Company Limited
Jun 15, 2026
Upgraded: Hold
Price Target: ¥1,500 → ¥1,200
Current: $950.00
Upside: +26.32%
M3, Inc.
May 28, 2026
Maintained: Hold
Price Target: ¥1,800 → ¥1,600
Current: $1,918.00
Upside: -16.58%
Kissei Pharmaceutical Co., Ltd.
May 25, 2026
Maintained: Buy
Price Target: ¥5,400 → ¥4,800
Current: $4,165.00
Upside: +15.25%
JCR Pharmaceuticals Co., Ltd.
Apr 16, 2026
Upgraded: Buy
Price Target: ¥750 → ¥900
Current: $456.00
Upside: +97.37%
Alfresa Holdings Corporation
Apr 14, 2026
Maintained: Hold
Price Target: ¥2,300 → ¥2,400
Current: $2,230.50
Upside: +7.60%
MediPal Holdings Corporation
Apr 14, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,700
Current: $2,752.00
Upside: -1.89%
Suzuken Co., Ltd.
Apr 14, 2026
Maintained: Buy
Price Target: ¥6,800 → ¥7,100
Current: $5,067.00
Upside: +40.12%
Toho Holdings Co., Ltd.
Apr 14, 2026
Maintained: Hold
Price Target: ¥5,800 → ¥5,000
Current: $4,010.00
Upside: +24.69%
Oct 16, 2025
Maintained: Buy
Price Target: ¥620
Current: $103.00
Upside: +501.94%
Aug 15, 2025
Maintained: Buy
Price Target: ¥620 → ¥710
Current: $238.00
Upside: +198.32%
Apr 21, 2025
Maintained: Hold
Price Target: ¥2,100
Current: $1,716.00
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: ¥2,000
Current: $896.00
Upside: n/a
Feb 27, 2025
Upgraded: Buy
Price Target: ¥1,900 → ¥2,800
Current: $1,022.50
Upside: n/a